ヘルスケア受託製造市場：製造タイプ別、エンドユーザー別-2025-2030年の世界予測

ヘルスケア受託製造市場は、2023年に1,860億米ドルと評価され、2024年には2,016億8,000万米ドルに達すると予測され、CAGR 8.49％で成長し、2030年には3,292億2,000万米ドルに達すると予測されています。

ヘルスケア受託製造は、製薬・医療機器企業が研究開発などのコアコンピタンスに集中できるよう、生産工程を専門の第三者企業にアウトソーシングすることを意味します。その必要性は、コスト効率、拡張性、規制遵守、専門的な専門知識へのアクセスに起因します。アプリケーション分野は、医薬品、バイオテクノロジー製品、医療機器、診断薬など多岐にわたる。最終用途には、病院、研究所、営利企業などが含まれます。市場の成長は、研究開発投資の増加、ジェネリック医薬品や生物製剤の旺盛な需要、医療技術の進歩によって推進されています。高齢化人口の急増と慢性疾患の有病率の上昇は、この需要をさらに増大させています。新興国市場は、拡大するヘルスケアへの取り組みと医療支出の増加により、絶好のビジネスチャンスを提供しています。企業は、現地製造の利点を活用し、地域企業と戦略的パートナーシップを結ぶことで利益を得ることができます。とはいえ、厳しい規制環境、複雑なロジスティクス、品質保証の課題、知的財産の問題といった課題に直面しています。これらを乗り切るためには、企業は強固な品質管理プロセスに投資し、国際規格への準拠を確保しなければならないです。イノベーションの道筋としては、3DプリンティングやIoTのような高度な製造技術の採用、ブロックチェーンによるサプライチェーンの合理化、予測的洞察のためのデータ分析の活用などが挙げられます。環境に優しい生産技術などの持続可能な慣行も、競合情勢における差別化のために有望です。市場は競争が激しく、かつ協調的であるため、メーカーは進化する顧客の要求や規制の変化に適応する柔軟性を維持する必要があります。市場のダイナミックな性質は、製品提供だけでなくサービス提供においても継続的な革新を求め、市場の変動への迅速な対応を保証します。新興市場と技術の進歩に戦略的に焦点を当てることで、企業は持続可能な成長を実現できます。最終的には、現地の消費者行動や規制のニュアンスを理解することが、ヘルスケア受託製造における世界なビジネスチャンスをつかむために不可欠となります。

市場力学：急速に進化するヘルスケア受託製造市場の主要市場インサイトを公開

ヘルスケア受託製造市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬企業によるエンド・ツー・エンド・サービスのアウトソーシング傾向の高まり
  • 受託製造企業による先端製造技術への投資の増加
  • 開発・製造のワンストップ受託機関に対する需要の高まり
• 市場抑制要因
  • 厳しい規制や法的枠組みと相まって、アウトソーシングにおけるコンプライアンスの問題
• 市場機会
  • 核医学と特殊医薬品への注目の高まり
  • 生物学的療法へのニーズの高まり
• 市場の課題
  • ヘルスケア受託製造組織の収益性に影響する稼働率の問題

ポーターのファイブフォース：ヘルスケア受託製造市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘルスケア受託製造市場における外部からの影響の把握

外部マクロ環境要因は、ヘルスケア受託製造市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘルスケア受託製造市場における競合情勢の把握

ヘルスケア受託製造市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘルスケア受託製造市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘルスケア受託製造市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘルスケア受託製造市場における成功への道筋を描く

ヘルスケア受託製造市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬会社によるエンドツーエンドのアウトソーシングの傾向が増加
    • 契約製造業者による先進製造技術への投資増加
    • ワンストップの契約開発・製造組織に対する需要の増加
  • 抑制要因
    • 厳格な規制と法的枠組みと相まってアウトソーシングにおけるコンプライアンス問題
  • 機会
    • 核医学と専門医薬品への注目が高まる
    • 生物学的療法の必要性の高まり
  • 課題
    • ヘルスケア受託製造組織の収益性に影響を与える生産能力利用の問題
• 市場セグメンテーション分析
  • 製造タイプ：製造プロセスの進歩により、契約製造を通じて多様なクライアントの要件に合わせたカスタマイズされたソリューションが提供されます。
  • エンドユーザー：契約製造業者が高度に複雑な生物学的製品の開発に参入
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘルスケア受託製造市場製造タイプ別

• アクセサリー製造
• 組立製造
• 部品製造
• デバイス製造
• 医薬品製造
  • 高度なドラッグデリバリー処方
  • API/バルク医薬品
  • 最終用量製剤
  • パッケージ

第7章 ヘルスケア受託製造市場：エンドユーザー別

• 医療機器企業
• 製薬・バイオ医薬品企業

第8章 南北アメリカのヘルスケア受託製造市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のヘルスケア受託製造市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのヘルスケア受託製造市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バイオメリック、プレシジョン・コンセプツ・メディカルとの合併を発表
  • PCIファーマ、イリノイ州の注射剤施設を5,000万米ドルかけて拡張する計画を発表
  • MedisurgeとSignal Medicalが戦略的提携を発表
• 戦略分析と提言

企業一覧

• AbbVie, Inc.
• Aenova Group
• Almac Group
• Baxter International, Inc.
• Biozoc Inc.
• Boehringer Ingelheim International GmbH
• Cambrex Corporation
• Curia Global, Inc.
• Evonik Industries AG
• Famar Group
• Jubilant Biosys Limited
• Lonza Group Ltd.
• Mitsubishi Tanabe Pharma Corporation
• Pfizer Inc.
• Pidolma Healthcare Private Limited
• Recipharm AB
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEALTHCARE CONTRACT MANUFACTURING MARKET DYNAMICS
• TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 31. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 33. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 48. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 50. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 51. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 53. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 103. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 105. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 115. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 117. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 118. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 120. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

The Healthcare Contract Manufacturing Market was valued at USD 186.00 billion in 2023, expected to reach USD 201.68 billion in 2024, and is projected to grow at a CAGR of 8.49%, to USD 329.22 billion by 2030.

Healthcare contract manufacturing involves outsourcing production processes to specialized third-party firms, enabling pharmaceutical and medical device companies to focus on core competencies like research and development. The necessity stems from cost efficiency, scalability, regulatory compliance, and access to specialized expertise. Application areas span pharmaceuticals, biotechnology products, medical devices, and diagnostics. End-use scopes include hospitals, research labs, and commercial enterprises. Market growth is propelled by increased R&D investments, robust demand for generics and biologics, and advancements in medical technology. The burgeoning aging population and rising prevalence of chronic diseases further amplify this demand. Developing markets offer ripe opportunities due to expansive healthcare initiatives and increasing healthcare spending. Companies can capitalize by leveraging local manufacturing benefits and forming strategic partnerships with regional firms. Nonetheless, the market faces hurdles such as stringent regulatory environments, complex logistics, quality assurance challenges, and intellectual property issues. To navigate these, firms must invest in robust quality control processes and ensure compliance with international standards. Innovation avenues entail embracing advanced manufacturing technologies like 3D printing and IoT, streamlining supply chains through blockchain, and utilizing data analytics for predictive insights. Sustainable practices, such as eco-friendly production techniques, are also promising for differentiation in a competitive landscape. The market is highly competitive yet collaborative, requiring manufacturers to maintain flexibility to adapt to evolving client demands and regulatory shifts. The market's dynamic nature calls for continuous innovation, not just in product offerings but also in service delivery, ensuring rapid response to market fluctuations. With a strategic focus on emerging markets and technological advancements, companies can achieve sustainable growth. Ultimately, understanding local consumer behavior and regulatory nuances will be crucial for seizing global opportunities in healthcare contract manufacturing.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Manufacturing Market

The Healthcare Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing trend of outsourcing end-to-end services by pharmaceutical companies
  • Rising investments in advanced manufacturing technologies by contract manufacturers
  • Increasing demand for one-stop-shop contract development & manufacturing organization
• Market Restraints
  • Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
• Market Opportunities
  • Growing focus on nuclear medicine and specialty drugs
  • Increasing need for biological therapies
• Market Challenges
  • Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Manufacturing Market

A detailed market share analysis in the Healthcare Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Manufacturing Market

A strategic analysis of the Healthcare Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Manufacturing Type, market is studied across Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, and Pharmaceutical Manufacturing. The Pharmaceutical Manufacturing is further studied across Advanced Drug Delivery Formulations, API/Bulk Drugs, Finished Dose Formulations, and Packaging.
• Based on End-Users, market is studied across Medical Device Companies and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • 5.1.1.2. Rising investments in advanced manufacturing technologies by contract manufacturers
    • 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
  • 5.1.2. Restraints
    • 5.1.2.1. Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing focus on nuclear medicine and specialty drugs
    • 5.1.3.2. Increasing need for biological therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
• 5.2. Market Segmentation Analysis
  • 5.2.1. Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
  • 5.2.2. End-User: Contract manufacturers expanded penetration to develop highly complex biological products
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Healthcare Contract Manufacturing Market, by Manufacturing Type

• 6.1. Introduction
• 6.2. Accessories Manufacturing
• 6.3. Assembly Manufacturing
• 6.4. Component Manufacturing
• 6.5. Device Manufacturing
• 6.6. Pharmaceutical Manufacturing
  • 6.6.1. Advanced Drug Delivery Formulations
  • 6.6.2. API/Bulk Drugs
  • 6.6.3. Finished Dose Formulations
  • 6.6.4. Packaging

7. Healthcare Contract Manufacturing Market, by End-Users

• 7.1. Introduction
• 7.2. Medical Device Companies
• 7.3. Pharmaceutical & Biopharmaceutical Companies

8. Americas Healthcare Contract Manufacturing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Healthcare Contract Manufacturing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Biomerics Announces Merger with Precision Concepts Medical
  • 11.3.2. PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
  • 11.3.3. Medisurge and Signal Medical Announce Strategic Partnership
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie, Inc.
• 2. Aenova Group
• 3. Almac Group
• 4. Baxter International, Inc.
• 5. Biozoc Inc.
• 6. Boehringer Ingelheim International GmbH
• 7. Cambrex Corporation
• 8. Curia Global, Inc.
• 9. Evonik Industries AG
• 10. Famar Group
• 11. Jubilant Biosys Limited
• 12. Lonza Group Ltd.
• 13. Mitsubishi Tanabe Pharma Corporation
• 14. Pfizer Inc.
• 15. Pidolma Healthcare Private Limited
• 16. Recipharm AB
• 17. Thermo Fisher Scientific Inc.